corporate_fare

Priothera S.A.S.

Address: 57 Avenue Du General De Gaulle

Sponsor Overview

assignment

Specializations

Hematologic Malignancies and Transplant-Related Care

Priothera S.A.S. focuses on clinical research in acute myeloid leukemia within the setting of allogeneic hematopoietic stem cell transplantation, with attention to treatment support around transplant-related care.

Acute myeloid leukemia
Allo-HCT
Adjunctive treatment
Maintenance therapy

The sponsor’s clinical interest is centered on therapeutic strategies used alongside transplantation to support patients with hematologic cancer during the post-transplant period.

Graft-versus-Host Disease Prevention

Its research activity includes GvHD prophylaxis, reflecting a focus on transplant complications and immune-related outcomes after hematopoietic cell transplantation.

GvHD prophylaxis
Immune modulation
Transplant complications
Post-transplant care

Clinical interest in this area is directed toward reducing transplant-associated immune injury in patients receiving allo-HCT.

Oncology Supportive Therapy

The sponsor’s trial portfolio points to interest in supportive oncology, particularly therapies intended to complement curative treatment pathways in blood cancers.

Supportive oncology
Post-remission management
Transplant adjunct therapy
Long-term disease control

This area is aligned with maintaining clinical stability in patients undergoing intensive transplant-based treatment for AML.

Trial Name	Country	Status
Phase III Randomized, Double-Blind, Placebo-Controlled Study of Mocravimod as Adjunctive and Maintenance Therapy in Acute Myeloid Leukemia Undergoing Allo-HCT	France Germany Italy Poland Romania Spain	Recruiting